Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2018

View Archived Issues

Fixing nuclear transport helps cells cope with premature, normal aging

Combinations offer new antibiotic possibilities

Researchers find novel mutation in CLCC1 gene tied to retinitis pigmentosa

New rat model of diabetic cardiopathy described

Aeromics initiates phase I study of AER-271 in healthy volunteers

APC11 has prognostic significance in colorectal cancer

Renal anemia treatment: new oral HIF prolyl hydroxylase inhibitor promotes EPO production in rodents

New abzymes presented for diagnosing multiple sclerosis

Initiation of phase II clinical trial of BPN-14770 in fragile X syndrome

miRagen launches phase II study of MRG-201

Positive phase I results announced for Vivus' VI-0106

New NFE2L2 activators identified at GlaxoSmithKline

Aurigene Discovery Technologies patents BRD4 inhibitors

Janssen Pharmaceutica discovers new menin/MLL interaction inhibitors

Dihydroceramide desaturase inhibitors presented by Centaurus Therapeutics

Hitgen describes Rho-associated protein kinase inhibitors

Vidac begins phase IIb trial of VCA-1102 in actinic keratosis

Kamada receives scientific advice from EMA for phase III trial of inhaled AAT

First patient enrolled in phase II study of subcutaneous MABp1 in hidradenitis suppurativa

SRI and Ionis enter research agreement to explore combination of technologies

European Commission grants marketing approval to Verkazia for severe vernal keratoconjunctivitis

Scynexis releases phase IIb study data for SCY-078 in vulvovaginal candidiasis

Arbutus offers update on pipeline progress

PPCS gene mutations linked to dilated cardiomyopathy

Zynerba starts pivotal study of ZYN-002 gel in fragile X syndrome

[177Lu]EB-PSMA-617 shows promising safety and efficacy in patients with mCRPC

[11C]LSN-3172176 brain PET tracer shows potential for quantification of M1 receptor in humans

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...